BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23991105)

  • 21. Proteinase-Activated Receptor 2 May Drive Cancer Progression by Facilitating TGF-β Signaling.
    Ungefroren H; Witte D; Rauch BH; Settmacher U; Lehnert H; Gieseler F; Kaufmann R
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29165389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Signaling Crosstalk of TGF-β/ALK5 and PAR2/PAR1: A Complex Regulatory Network Controlling Fibrosis and Cancer.
    Ungefroren H; Gieseler F; Kaufmann R; Settmacher U; Lehnert H; Rauch BH
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29795022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensitization of ASIC3 by proteinase-activated receptor 2 signaling contributes to acidosis-induced nociception.
    Wu J; Liu TT; Zhou YM; Qiu CY; Ren P; Jiao M; Hu WP
    J Neuroinflammation; 2017 Jul; 14(1):150. PubMed ID: 28754162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. microRNA-9 suppresses the proliferation, invasion and metastasis of gastric cancer cells through targeting cyclin D1 and Ets1.
    Zheng L; Qi T; Yang D; Qi M; Li D; Xiang X; Huang K; Tong Q
    PLoS One; 2013; 8(1):e55719. PubMed ID: 23383271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteinase-activated receptor2 agonists upregulate granulocyte colony-stimulating factor, IL-8, and VCAM-1 expression in human bronchial fibroblasts.
    Ramachandran R; Morice AH; Compton SJ
    Am J Respir Cell Mol Biol; 2006 Jul; 35(1):133-41. PubMed ID: 16498082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kallikrein-related peptidase signaling in colon carcinoma cells: targeting proteinase-activated receptors.
    Chung H; Hamza M; Oikonomopoulou K; Gratio V; Saifeddine M; Virca GD; Diamandis EP; Hollenberg MD; Darmoul D
    Biol Chem; 2012 Apr; 393(5):413-20. PubMed ID: 22505523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-27a Promotes the Proliferation and Invasiveness of Colon Cancer Cells by Targeting SFRP1 through the Wnt/β-Catenin Signaling Pathway.
    Ba S; Xuan Y; Long ZW; Chen HY; Zheng SS
    Cell Physiol Biochem; 2017; 42(5):1920-1933. PubMed ID: 28772260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.
    Morris DR; Ding Y; Ricks TK; Gullapalli A; Wolfe BL; Trejo J
    Cancer Res; 2006 Jan; 66(1):307-14. PubMed ID: 16397244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. shRNA-induced silencing of Ras-related C3 botulinum toxin substrate 1 inhibits the proliferation of colon cancer cells through upregulation of BAD and downregulation of cyclin D1.
    Huang YS; Jie N; Zhang YX; Zou KJ; Weng Y
    Int J Mol Med; 2018 Mar; 41(3):1397-1408. PubMed ID: 29286138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
    Wu Z; He B; He J; Mao X
    Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upregulation of Protease-Activated Receptor 2 Promotes Proliferation and Migration of Human Vascular Smooth Muscle Cells (VSMCs).
    Wei M; Liu Y; Zheng M; Wang L; Ma F; Qi Y; Liu G
    Med Sci Monit; 2019 Nov; 25():8854-8862. PubMed ID: 31756174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factor VIIa regulates the expression of caspase-3, MMP-9, and CD44 in SW620 colon cancer cells involving PAR2/MAPKs/NF-κB signaling pathways.
    Wu Y; Zhang X; Zhou H; Chen D; Xie H; Mu Y; Wu B; Yan J
    Cancer Invest; 2013 Jan; 31(1):7-16. PubMed ID: 23170789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PAR2 deficiency enhances myeloid cell-mediated immunosuppression and promotes colitis-associated tumorigenesis.
    Ke Z; Wang C; Wu T; Wang W; Yang Y; Dai Y
    Cancer Lett; 2020 Jan; 469():437-446. PubMed ID: 31733286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of intracellular Ca2+ in the regulation of proteinase-activated receptor-2 mediated nuclear factor kappa B signalling in keratinocytes.
    Macfarlane SR; Sloss CM; Cameron P; Kanke T; McKenzie RC; Plevin R
    Br J Pharmacol; 2005 Jun; 145(4):535-44. PubMed ID: 15821758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The p38 mitogen-activated protein kinase pathway plays a critical role in PAR2-induced endothelial IL-8 production and leukocyte adhesion.
    Pan SL; Tao KY; Guh JH; Sun HL; Huang DY; Chang YL; Teng CM
    Shock; 2008 Nov; 30(5):496-502. PubMed ID: 18277946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteinase-activated receptor 2 promotes tumor cell proliferation and metastasis by inducing epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma.
    Sun L; Li PB; Yao YF; Xiu AY; Peng Z; Bai YH; Gao YJ
    World J Gastroenterol; 2018 Mar; 24(10):1120-1133. PubMed ID: 29563756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA-ZDHHC8P1 promotes the progression and metastasis of colorectal cancer by targeting miR-34a.
    Li C; Liu T; Zhang Y; Li Q; Jin LK
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1476-1486. PubMed ID: 30840269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NFκB-mediated cyclin D1 expression by microRNA-21 influences renal cancer cell proliferation.
    Bera A; Ghosh-Choudhury N; Dey N; Das F; Kasinath BS; Abboud HE; Choudhury GG
    Cell Signal; 2013 Dec; 25(12):2575-86. PubMed ID: 23981302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of proteinase-activated receptor-2 (PAR2) is androgen-dependent in stromal cell line (hPCPs) from benign prostatic hyperplasia.
    Mannowetz N; Würdinger R; Zippel A; Aumüller G; Wennemuth G
    Prostate; 2010 Sep; 70(12):1350-8. PubMed ID: 20623639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of miR-34a contributes to the proliferation and migration of laryngeal carcinoma cells by targeting cyclin D1.
    Ye J; Li L; Feng P; Wan J; Li J
    Oncol Rep; 2016 Jul; 36(1):390-8. PubMed ID: 27220728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.